Filing Flows › Comparisons › IMDX vs CDIO
Insight Molecular Diagnostics vs Cardio Diagnostics Holdings: IMDX and CDIO compared
Insight Molecular Diagnostics is the larger company: $239K of revenue in its latest quarter (Q2 2026) against $4K for Cardio Diagnostics Holdings (Q3 2026). Cardio Diagnostics Holdings is growing faster (+26% against -54% a year earlier).
Where the money goes: IMDX and CDIO
Insight Molecular Diagnostics (IMDX) · Q2 2026
Insight Molecular Diagnostics, Q2 2026: revenue $239K (-54% year over year), net loss $11.3M, operating cash flow −$9.3M. The chart follows the revenue to costs, profit and cash.
Cardio Diagnostics Holdings (CDIO) · Q3 2026
Cardio Diagnostics Holdings, Q3 2026: revenue $4K (+26% year over year), net loss $1.7M, operating cash flow −$1.5M. The chart follows the revenue to costs, profit and cash.
| Insight Molecular Diagnostics (IMDX) | Cardio Diagnostics Holdings (CDIO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $239K | $4K |
| Revenue growth, Y/Y | -54% | +26% |
| Operating margin | n/m | n/m |
| Net earnings | −$11.3M | −$1.7M |
| Operating cash flow | −$9.3M | −$1.5M |
Where the revenue comes from
Insight Molecular Diagnostics
- Laboratory Services: $218K (91%)
- Kitted Products: $21K (9%)
Questions
Which is bigger, Insight Molecular Diagnostics or Cardio Diagnostics Holdings?
Insight Molecular Diagnostics is the larger company: $239K of revenue in its latest quarter (Q2 2026) against $4K for Cardio Diagnostics Holdings (Q3 2026).
Is Insight Molecular Diagnostics or Cardio Diagnostics Holdings growing faster?
Cardio Diagnostics Holdings is growing faster (+26% against -54% a year earlier).
More: Insight Molecular Diagnostics earnings · how Insight Molecular Diagnostics makes money · Cardio Diagnostics Holdings earnings · how Cardio Diagnostics Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 10, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.